TransMedics (TMDX) FCF Margin (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | TransMedics | 2.32 Bn | 1.86 Bn | 101.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,455.00 |
| Dec 31, 2025 | 2,876.00 |
| Sep 30, 2025 | -3,932.00 |
| Jun 30, 2025 | 6,093.00 |
| Mar 31, 2025 | -1,802.00 |
| Dec 31, 2024 | 837.00 |
| Sep 30, 2024 | -1,532.00 |
| Jun 30, 2024 | 2,695.00 |
| Mar 31, 2024 | -1,410.00 |
| Dec 31, 2023 | 1,879.00 |
| Sep 30, 2023 | 594.00 |
| Jun 30, 2023 | 551.00 |
| Mar 31, 2023 | 2,694.00 |
| Dec 31, 2022 | 619.00 |
| Sep 30, 2022 | -1,278.00 |
| Jun 30, 2022 | 8,694.00 |
| Mar 31, 2022 | -2,657.00 |
| Dec 31, 2021 | 7,610.00 |
| Sep 30, 2021 | -11,329.00 |
| Jun 30, 2021 | 3,976.00 |
| Mar 31, 2021 | -500.00 |
| Dec 31, 2020 | -2,345.00 |
| Sep 30, 2020 | 17,958.00 |
| Jun 30, 2020 | -15,280.00 |
| Mar 31, 2020 | 1,862.00 |
| Dec 28, 2019 | -4,250.00 |
| Sep 28, 2019 | 13,621.00 |
| Jun 29, 2019 | -5,942.00 |
| Mar 30, 2019 | 2,101.00 |
| Dec 29, 2018 | -2,029.00 |
| Sep 29, 2018 | 10,005.00 |
| Jun 30, 2018 | -331.00 |